Importantly, we prospectively analyzed the serum levels of 50 patients undergoing allo-HSCT (Supplementary Table 1) and found that the serum levels of IL-1α in patients with severe GVHD were significantly higher than those in patients with no or mild GVHD (Fig. 5e). This evidence concerns the gene IL1A and graft versus host disease.